Transcranial Direct Stimulation for Persistent Fatigue Treatment Post-COVID-19
NCT ID: NCT05252481
Last Updated: 2022-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
47 participants
INTERVENTIONAL
2022-04-01
2022-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
tDCS in Post-COVID Syndrome: Comparison of Two Targets
NCT05753202
Transcranial Direct Current Stimulation (tDCS) for Post COVID-19 Fatigue
NCT04876417
Impact of Transcranial Direct Current Stimulation on Fatigability and Fatigue Induced by a Selective Attention Task
NCT02840214
Protocol for Assistance to Patients With Long Covid-19 Undergoing Treatment With HD-tDCS
NCT05289115
tDCS in the Management of Post-COVID Disorders
NCT06074848
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active tDCS
Transcranial current direct stimulation. 8 days.
Active tDCS
Eight sessions of transcranial current direct stimulation
Sham tDCS
Sham transcranial current direct stimulation. 8 days.
Sham tDCS
Eight sessions of transcranial current direct stimulation (sham)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active tDCS
Eight sessions of transcranial current direct stimulation
Sham tDCS
Eight sessions of transcranial current direct stimulation (sham)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fatigue linked to COVID-19
* No diagnosis of neurological, psychiatric or medical disorder with potential impact on fatigue.
Exclusion Criteria
* History of traumatic brain lesion or central nervous system infection previous to COVID-19
* Radiotherapy or chemotherapy for cancer
* Severe sensorial deficits
* Drugs or uncontrolled medical disorder with potential impact on fatigue.
* History of abuse of alcohol or other toxics.
* Any contraindication for tDCS (metallic implants, brain devices, pacemakers, head injuries).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital San Carlos, Madrid
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jordi A Matias-Guiu
PhD MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Clínico San Carlos.
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-120
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.